Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Genera Biosystems Ltd (GBI) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12156
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is a molecular diagnostic test for the detection and genotyping of high risk and low risk types of human papillomavirus that cause cervical cancer or genital warts. GBL uses AmpaSand beads technology to create identifiable clusters of beads that can be distinguished in a conventional flow cytometer. The company provides products to detect influenzaA, influenzaB, influenza A H1N1, influenzaA H5N1, respiratory syncytial virus, human metapneumovirus, adenovirus, rhinovirus, bordetella pertussis, and chlamydophila pneumonia. It collaborates with pathology customers and IVD companies. GBL is headquartered in Melbourne, Victoria, Australia.

Genera Biosystems Ltd (GBI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genera Biosystems Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Genera Biosystems Enters into Distribution Agreement with Beckman Coulter Life Sciences 10
Genera Biosystems Enters into Co-Marketing Agreement with Beckman Coulter Life Sciences 11
Genera Biosystems Enters into Distribution Agreement with Genecell Diagnostics 12
Equity Offering 13
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 13
Genera Biosystems Completes Private Placement Of Shares For US$0.12 Million 14
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 15
Debt Offering 16
Genera Biosystems Raises USD0.5 Million in Second Tranche of Private Placement of Notes 16
Genera Biosystems Raises USD1.6 Million in First Tranche of Private Placement of Notes 17
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 18
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 19
Genera Biosystems Completes Private Placement Of Notes Due 2015 For US$0.34 Million 20
Genera Biosystems Ltd – Key Competitors 21
Genera Biosystems Ltd – Key Employees 22
Genera Biosystems Ltd – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Nov 01, 2018: Genera Biosystems: Quarterly cash flow & business update for 30th June 2018 24
Corporate Communications 25
Nov 30, 2018: Genera Biosystems: changes to the board of directors 25
Other Significant Developments 26
May 01, 2018: Genera Biosystems:Quarterly Cash Flow & Business Update 26
Nov 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 27
Jul 31, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 28
May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017 30
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Genera Biosystems Ltd, Medical Equipment, Key Facts, 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Deals By Market, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Genera Biosystems Enters into Distribution Agreement with Beckman Coulter Life Sciences 10
Genera Biosystems Enters into Co-Marketing Agreement with Beckman Coulter Life Sciences 11
Genera Biosystems Enters into Distribution Agreement with Genecell Diagnostics 12
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 13
Genera Biosystems Completes Private Placement Of Shares For US$0.12 Million 14
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 15
Genera Biosystems Raises USD0.5 Million in Second Tranche of Private Placement of Notes 16
Genera Biosystems Raises USD1.6 Million in First Tranche of Private Placement of Notes 17
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 18
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 19
Genera Biosystems Completes Private Placement Of Notes Due 2015 For US$0.34 Million 20
Genera Biosystems Ltd, Key Competitors 21
Genera Biosystems Ltd, Key Employees 22

List of Figures
Genera Biosystems Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Genera Biosystems Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Genera Biosystems Ltd (GBI):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tokyo Electron Ltd (8035):企業の財務・戦略的SWOT分析
    Tokyo Electron Ltd (8035) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • 4P-Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary 4P-Pharma SAS (4P-Pharma) focuses on the development of novel therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline product portfolio includes new chemical entities, biologics, added value generics and fixed dose combinations. Its pipeline candidates targets …
  • E.ON SE (EOAN)-石油・ガス分野:企業M&A・提携分析
    Summary E.ON SE (E.ON), formerly E.ON AG, is an energy company that generates electricity, produces, stores, transports, and supplies gas and conducts trading, carbon sourcing, and electricity and gas distribution. It generates power from diverse fuel sources including wind, hydro, nuclear, coal, na …
  • Zest Dental Solutions:医療機器:M&Aディール及び事業提携情報
    Summary Zest Dental Solutions (Zest Dental), formerly ZEST Anchors LLC is a medical device manufacturing company that manufactures, develops, and distributes dental solutions for the treatment of edentulous patients. The company’s products include dental removal tool, attachment processing materials …
  • The Scripps Research Institute-医療機器分野:企業M&A・提携分析
    Summary The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institut …
  • BOC Aviation Limited (2588):企業の財務・戦略的SWOT分析
    BOC Aviation Limited (2588) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • National Research Corp (NRCIB):企業の財務・戦略的SWOT分析
    Summary National Research Corp (NRC) is a healthcare organization that provides market insight solutions. The company’s solutions include experience collection, market insights, transparency of experience data and governance. It offers market insights solutions that allow the tracking of awareness, …
  • Sohu.com Inc. (SOHU):企業の財務・戦略的SWOT分析
    Sohu.com Inc. (SOHU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Genomic Expression Inc:企業の製品パイプライン分析
    Summary Genomic Expression Inc (Genomic Expression) is a provider of cancer diagnostics services that offers treatments for cancer diagnostics for personalized medicine. The company offers products such as sample sequencing sample preparation kit and analytical platform. Its sequencing platform prov …
  • Merrimack Pharmaceuticals Inc (MACK):医療機器:M&Aディール及び事業提携情報
    Summary Merrimack Pharmaceuticals Inc (Merrimack) is a clinical stage biopharmaceutical company that develops and commercializes medicines for the treatment of various types of cancers. The company’s marketed portfolio consists of Onivyde (irinotecan liposome injection) that encases irinotecan (mark …
  • PetroChina Company Limited:企業の戦略・SWOT・財務情報
    PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report Summary PetroChina Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Countrywide Plc:企業のM&A・事業提携・投資動向
    Countrywide Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Countrywide Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • UNITIKA LTD.:企業の戦略・SWOT・財務情報
    UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report Summary UNITIKA LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Aquinox Pharmaceuticals Inc (AQXP):製薬・医療:M&Aディール及び事業提携情報
    Summary Aquinox Pharmaceuticals Inc (Aquinox) is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation, inflammatory pain, and blood cancers. The company's lead drug candidate include AQX-1125, is a small molecular activator of SHIP1 which is a …
  • Nimbus Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Nimbus Therapeutics LLC (Nimbus Therapeutics), formerly Nimbus Discovery LLC, is a biotechnology company that develops medicines for critical diseases such as metabolic disease, cancer, and immune-inflammatory disorders. The company harnesses its expertise in deep computational chemistry to …
  • SEACOR Holdings Inc.:企業の戦略・SWOT・財務分析
    SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary SEACOR Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AENZA SAA (AENZAC1):企業の財務・戦略的SWOT分析
    AENZA SAA (AENZAC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mitsui Fudosan Co., Ltd.:戦略・SWOT・企業財務分析
    Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mitsui Fudosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CareDx Inc (CDNA):企業の製品パイプライン分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and …
  • Inovalon Holdings Inc (INOV):企業の財務・戦略的SWOT分析
    Summary Inovalon Holdings Inc (Inovalon), formerly MedAssurant Inc is a technology company that provides cloud-based platforms for healthcare industry. The company designs, develops and distributes software tools to provide healthcare and financial improvement solutions. It provides data driven solu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆